Aileron Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aileron Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Aileron Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.07M, a 206% decline year-over-year.
  • Aileron Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$29.6M, a 116% decline year-over-year.
  • Aileron Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$16.3M, a 41.1% increase from 2022.
  • Aileron Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$27.6M, a 3.92% decline from 2021.
  • Aileron Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$26.6M, a 29.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$16.3M +$11.4M +41.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 -$27.6M -$1.04M -3.92% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 -$26.6M -$6.11M -29.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$20.5M +$9.46M +31.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$30M +$1.95M +6.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 -$31.9M -$8.89M -38.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$23M -$4.84M -26.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 -$18.2M -$5.28M -40.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$12.9M Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.